BMNR
Bitmine Immersion Technologies, Inc.
There isn't enough reported data to score BMNR yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
BMNR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| N/A | |
| N/A |
BMNR's revenue is currently strong, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMNR.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BMNR PE Valuation
BMNR has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
BMNR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for BMNR, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BMNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.14 | — |
| Q3 2024 | -$1.40 | -$0.40 |
| Q2 2024 | -$1.40 | -$0.45 |
| Q1 2024 | -$1.40 | -$0.45 |
| Q4 2023 | -$1.20 | -$0.40 |
| Q3 2023 | -$1.00 | $0.00 |
JPM has the stronger earnings trend. Trailing diluted EPS is down 1,036% for BMNR versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
BMNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +4802% |
| Q2 2026 | $46.5M | +2168% |
| Q1 2026 | $11M | +628% |
| Q4 2025 | $2.3M | +91% |
| Q3 2025 | $1.3M | +94% |
| Q2 2025 | $2.1M | +67% |
| Q1 2025 | $1.5M | +70% |
| Q4 2024 | $1.2M | +135% |
BMNR has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4347% | -29352 points |
| Q2 2026 | -26% | -2.7 points |
| Q1 2026 | -34785% | -34725 points |
| Q4 2025 | -238565% | -238491 points |
| Q3 2025 | 33699% | +33796 points |
| Q2 2025 | -23% | +21 points |
| Q1 2025 | -60% | +13 points |
| Q4 2024 | -74% | +46 points |
BMNR has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
BMNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.6M | -$11M |
| Q2 2026 | $29M | +1629% |
| Q1 2026 | -$88.2M | -$88M |
| Q4 2025 | -$228.7M | -$228.6M |
| Q3 2025 | -$6.6M | -3106% |
| Q2 2025 | $1.7M | +$1.7M |
| Q1 2025 | -$214.2K | -$77.6K |
| Q4 2024 | -$113.9K | +$11.1K |
BMNR's free cash flow was −$306M over the past year, against −$5M the year before. Free cash flow isn't a meaningful measure for financial services companies like BMNR.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over BMNR on cash flow, with more consistent year-over-year improvement.
BMNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +97.2M shares |
| 1 year | +27721% | +550M shares |
| 3 years | +25500% | +550M shares |
BMNR has 552M diluted shares, up 27721% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BMNR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BMNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.2x | Net Cash |
| Q3 2014 | 37.0x | High |
| Q1 2014 | 557.6x | High |
BMNR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BMNR.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BMNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 19.2 | Oversold |
BMNR's weekly RSI is 41 (neutral) and its Stochastic is 19 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BMNR PE vs Financial Services Sector
BMNR has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BMNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.4 | 18% below |
| 20 week MA | $20.9 | 12% below |
| 50 week MA | $22.0 | 16% below |
JPM has stronger trend alignment. BMNR is above 0 of 3 weekly averages versus JPM above 4 of 5.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
BMNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.0 | $28.3 | +89% |
| 2026 YTD | $28.3 | $18.5 | -35% |
BMNR has finished every year since 2025 higher, and it's down 35% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over BMNR on returns for 2026, with the stronger performance.